Stock Events

Stock Events

Cardiac Biotech Solutions 

$0.036000
4
-$0.00-10% Wednesday 20:00

Statistics

Day High
0.0399
Day Low
0.0399
52W High
0.063
52W Low
0.016
Volume
10,000
Avg. Volume
8,976
Mkt Cap
5.96M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q2 2016
Q3 2016
Q1 2017
Q2 2017
Q4 2017
Q1 2018
Q2 2018
-0.01
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.0019

Financials

-585.62%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
153,000Revenue
-896,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories is a competitor because it also operates in the medical devices and healthcare sector, offering diagnostic products and services similar to CB Scientific.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc engages in the development, manufacturing, and marketing of device-based medical therapies, which competes with CB Scientific's offerings in the medical device space.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. provides a portfolio of healthcare products, including renal and hospital products, which competes with CB Scientific's medical diagnostic and research tools.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing with CB Scientific in the medical devices market.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation is involved in the development, manufacturing, and marketing of medical devices, which directly competes with CB Scientific's product offerings.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. designs, manufactures, and markets orthopedic reconstructive products; competing with CB Scientific in the broader medical devices sector.
Edwards Lifesciences
EW
Mkt Cap52B
Edwards Lifesciences Corporation specializes in heart valves and hemodynamic monitoring, competing with CB Scientific in the medical devices and diagnostics market.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation operates in the medical, professional, industrial, and commercial sectors, offering products and services that compete with CB Scientific's diagnostics and research offerings.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing with CB Scientific in the life sciences and diagnostics sectors.

About

Operating globally through its international subsidiaries, Cardiac Biotech Solutions Inc. delivers advanced products and services for non-invasive, mobile cardiac monitoring. The company's portfolio includes FDA and CE-approved EKG devices, sophisticated cloud-based data acquisition software, and intuitive smartphone applications compatible with both iOS and Android platforms. These solutions are designed to boost patient engagement for individuals prone to irregular heart rhythms, simultaneously providing medical professionals with highly accurate diagnostic insights. Furthermore, its wholly owned U.S. subsidiary, My-Cardia (USA), Inc., focuses on creating wearable ECG recording devices that patients can utilize in an ambulatory setting for periods extending up to 30 days.
Show more...
CEO
Charles K. Martin
Employees
4
Country
United States
ISIN
US12506E1038

Listings

OTC Link
US
CBSC

0 Comments

Share your thoughts

FAQ

What is Cardiac Biotech Solutions stock price today?▼
The current price of CBSC is $0.04 USD — it has decreased by -10% in the past 24 hours. Watch Cardiac Biotech Solutions stock price performance more closely on the chart.
What is Cardiac Biotech Solutions stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Cardiac Biotech Solutions stocks are traded under the ticker CBSC.
Is Cardiac Biotech Solutions stock price growing?▼
CBSC stock has fallen by -10% compared to the previous week, the month change is a +20% rise, over the last year Cardiac Biotech Solutions has showed a -5.26% decrease.
What is Cardiac Biotech Solutions market cap?▼
Today Cardiac Biotech Solutions has the market capitalization of 5.96M
What were Cardiac Biotech Solutions earnings last quarter?▼
CBSC earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cardiac Biotech Solutions revenue for the last year?▼
Cardiac Biotech Solutions revenue for the last year amounts to 153,000 USD.
What is Cardiac Biotech Solutions net income for the last year?▼
CBSC net income for the last year is -896,000 USD.
How many employees does Cardiac Biotech Solutions have?▼
As of September 05, 2026, the company has 4 employees.
In which sector is Cardiac Biotech Solutions located?▼
Cardiac Biotech Solutions operates in the Health & Wellness sector.
When did Cardiac Biotech Solutions complete a stock split?▼
The last stock split for Cardiac Biotech Solutions was on February 16, 2016 with a ratio of 1:75.
Where is Cardiac Biotech Solutions headquartered?▼
Cardiac Biotech Solutions is headquartered in Las Vegas, United States.